BIOMAT Database Logo BIOMAT Database Logo

Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers. 2019

Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, October University for Modern Science and Arts (MSA), Cairo 12611, Egypt. anewahie@msa.eun.eg.

The quinoxaline scaffold is a promising platform for the discovery of active chemotherapeutic agents. Three series of quinoxaline derivatives were synthesized and biologically evaluated against three tumor cell lines (HCT116 human colon carcinoma, HepG2, liver hepatocellular carcinoma and MCF-7, human breast adenocarcinoma cell line), in addition to VEGFR-2 enzyme inhibition activity. Compounds VIId, VIIIa, VIIIc, VIIIe and XVa exhibited promising activity against the tested cell lines and weak activity against VEGFR-2. Compound VIIIc induced a significant disruption in the cell cycle profile and cell cycle arrest at the G2/M phase boundary. In further assays, the cytotoxic effect of the highly active compounds was determined using a normal Caucasian fibroblast-like fetal lung cell line (WI-38). Compound VIIIc could be considered as a lead compound that merits further optimization and development as an anti-cancer and an apoptotic inducing candidate against the HCT116 cell line.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011810 Quinoxalines Quinoxaline
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Design, synthesis, and molecular docking studies of novel quinoxaline derivatives as anticancer agents.
August 2023, Chemical biology & drug design,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis.
May 2021, Bioorganic chemistry,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Synthesis of pro-apoptotic indapamide derivatives as anticancer agents.
December 2015, Journal of enzyme inhibition and medicinal chemistry,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
New pyranopyrazole based derivatives: Design, synthesis, and biological evaluation as potential topoisomerase II inhibitors, apoptotic inducers, and antiproliferative agents.
March 2024, Bioorganic chemistry,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Design, Synthesis, and Biological Evaluation of quinoxaline bearing tetrahydropyridine derivatives as anticancer, antioxidant, and anti-tubercular agents.
August 2022, Current computer-aided drug design,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Design, synthesis and molecular docking of new [1,2,4] triazolo[4,3-a]quinoxaline derivatives as anticancer agents targeting VEGFR-2 kinase.
August 2022, Molecular diversity,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents.
February 2021, Molecules (Basel, Switzerland),
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluation.
June 2023, Future medicinal chemistry,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Design and synthesis of celastrol derivatives as anticancer agents.
May 2015, European journal of medicinal chemistry,
Aliya M S El Newahie, and Yassin M Nissan, and Nasser S M Ismail, and Dalal A Abou El Ella, and Sohair M Khojah, and Khaled A M Abouzid
Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents.
January 2022, Russian journal of bioorganic chemistry,
Copied contents to your clipboard!